Use of E. coli strains expressing high level of alpha-Gal to modulate immunity and provide protection against infectious diseases in animals

The present invention concerns an E. coli strains expressing high level of α-Gal, in particular selected in the group consisting of E. coli Nissle 1917 strain, E. coli O111 strain, E. coli O86:B7 strain, and mixture thereof, as a probiotic and/or feed additive and/or oral vaccine in a non-human anim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DE LA FUENTE-GARCIA, Jose de Jesus, TORRES-MARAVILLA, Edgar, GUILLOT, Jacques, RISCO-CASTILLO, Veronica, HOLZER, Astrid Sibylle, CABEZAS-CRUZ, Alejandro, BERMUDEZ-HUMARAN, Luis, MATEOS-HERNANDEZ, Lourdes
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention concerns an E. coli strains expressing high level of α-Gal, in particular selected in the group consisting of E. coli Nissle 1917 strain, E. coli O111 strain, E. coli O86:B7 strain, and mixture thereof, as a probiotic and/or feed additive and/or oral vaccine in a non-human animal, in particular fish and poultry, to prevent and/or reduce an infectious disease caused by a pathogen expressing α-Gal on its surface.